Literature DB >> 20308586

Combinatorial libraries against libraries for selecting neoepitope activation-specific antibodies.

Xuebo Hu1, Sungkwon Kang, Craig Lefort, Minsoo Kim, Moonsoo M Jin.   

Abstract

A systematic approach to the discovery of conformation-specific antibodies or those that recognize activation-induced neoepitopes in signaling molecules and enzymes will be a powerful tool in developing antibodies for basic science and therapy. Here, we report the isolation of antibody antagonists that preferentially bind activated integrin Mac-1 (alpha(M)beta(2)) and are potent in blocking neutrophil adhesion and migration. A novel strategy was developed for this task, consisting of yeast surface display of Mac-1 inserted (I) domain library, directed evolution to isolate active mutants of the I domain, and screening of phage display of human antibody library against the active I domain in yeast. Enriched antibody library was then introduced into yeast surface two-hybrid system for final quantitative selection of antibodies from monomeric antigen-antibody interaction. This led to highly efficient isolation of intermediate to high affinity antibodies, which preferentially reacted with the active I domain, antagonized the I domain binding to intercellular adhesion molecule (ICAM)-1, complement C3 fragment iC3b, and fibronectin, and potently inhibited neutrophil migration on fibrinogen. The strategy demonstrated herein can be broadly applicable to developing antibodies against modular domains that switch between inactive and active conformations, particularly toward the discovery of antibody antagonists in therapeutic and diagnostic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308586      PMCID: PMC2851959          DOI: 10.1073/pnas.0914358107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Integrin antagonists.

Authors:  G P Curley; H Blum; M J Humphries
Journal:  Cell Mol Life Sci       Date:  1999-10-30       Impact factor: 9.261

2.  Antibody arrays for high-throughput screening of antibody-antigen interactions.

Authors:  R M de Wildt; C R Mundy; B D Gorick; I M Tomlinson
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

Review 3.  Antibody discovery: phage display.

Authors:  Titus Kretzschmar; Thomas von Rüden
Journal:  Curr Opin Biotechnol       Date:  2002-12       Impact factor: 9.740

4.  Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo.

Authors:  M Shimaoka; C Lu; R T Palframan; U H von Andrian; A McCormack; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation.

Authors:  Motomu Shimaoka; Tsan Xiao; Jin-Huan Liu; Yuting Yang; Yicheng Dong; Chang-Duk Jun; Alison McCormack; Rongguang Zhang; Andrzej Joachimiak; Junichi Takagi; Jia-Huai Wang; Timothy A Springer
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

Review 6.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

7.  Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation.

Authors:  C Lu; M Ferzly; J Takagi; T A Springer
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

8.  Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast.

Authors:  Yong-Sung Kim; Rashna Bhandari; Jennifer R Cochran; John Kuriyan; K Dane Wittrup
Journal:  Proteins       Date:  2006-03-01

Review 9.  Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases.

Authors:  Helena Yusuf-Makagiansar; Meagan E Anderson; Tatyana V Yakovleva; Joseph S Murray; Teruna J Siahaan
Journal:  Med Res Rev       Date:  2002-03       Impact factor: 12.944

Review 10.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  14 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Isolation of αL I domain mutants mediating firm cell adhesion using a novel flow-based sorting method.

Authors:  Lauren R Pepper; Ranganath Parthasarathy; Gregory P Robbins; Nicholas N Dang; Daniel A Hammer; Eric T Boder
Journal:  Protein Eng Des Sel       Date:  2013-06-19       Impact factor: 1.650

3.  Recombinant renewable polyclonal antibodies.

Authors:  Fortunato Ferrara; Sara D'Angelo; Tiziano Gaiotto; Leslie Naranjo; Hongzhao Tian; Susanne Gräslund; Elena Dobrovetsky; Peter Hraber; Fridtjof Lund-Johansen; Silvia Saragozza; Daniele Sblattero; Csaba Kiss; Andrew R M Bradbury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 4.  Cells and cell lysates: a direct approach for engineering antibodies against membrane proteins using yeast surface display.

Authors:  Benjamin J Tillotson; Yong Ku Cho; Eric V Shusta
Journal:  Methods       Date:  2012-03-23       Impact factor: 3.608

Review 5.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

6.  Cell surface assembly of HIV gp41 six-helix bundles for facile, quantitative measurements of hetero-oligomeric interactions.

Authors:  Xuebo Hu; Piyali Saha; Xiaoyue Chen; Dogeun Kim; Mahesh Devarasetty; Raghavan Varadarajan; Moonsoo M Jin
Journal:  J Am Chem Soc       Date:  2012-08-28       Impact factor: 15.419

7.  Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panning.

Authors:  Lawrence A Stern; Ian A Schrack; Sadie M Johnson; Aakash Deshpande; Nathaniel R Bennett; Lauren A Harasymiw; Melissa K Gardner; Benjamin J Hackel
Journal:  Biotechnol Bioeng       Date:  2016-06-30       Impact factor: 4.530

8.  Cross-domain inhibition of TACE ectodomain.

Authors:  Christopher J Tape; Sofie H Willems; Sarah L Dombernowsky; Peter L Stanley; Marton Fogarasi; Willem Ouwehand; John McCafferty; Gillian Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

9.  Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeast.

Authors:  Xiaoling Gu; Yogindra Vedvyas; Xiaoyue Chen; Tanwi Kaushik; Chang-Il Hwang; Xuebo Hu; Alexander Y Nikitin; Moonsoo M Jin
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 10.  Recent advances in the field of anti-cancer immunotherapy.

Authors:  Henrique Neves; Hang Fai Kwok
Journal:  BBA Clin       Date:  2015-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.